These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Two-piece customized mold technique for high-dose-rate brachytherapy on cancers of the buccal mucosa and lip. Matsuzaki H; Takemoto M; Hara M; Unetsubo T; Yanagi Y; Katsui K; Katayama N; Yoshio K; Takenobu T; Kuroda M; Kanazawa S; Asaumi J Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jan; 113(1):118-25. PubMed ID: 22677692 [TBL] [Abstract][Full Text] [Related]
9. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer. Lee LJ; Viswanathan AN Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies. Bajwa HK; Singareddy R; Krishnam Raju A Brachytherapy; 2020; 19(5):669-673. PubMed ID: 32466952 [TBL] [Abstract][Full Text] [Related]
11. High-dose-rate interstitial brachytherapy in early stage buccal mucosa and lip cancer: report on 12 consecutive patients and review of the literature. Vavassori A; Gherardi F; Colangione SP; Fodor C; Cattani F; Lazzari R; Calabrese L; Bruschini R; Alterio D; Jereczek-Fossa BA; Orecchia R Tumori; 2012; 98(4):471-7. PubMed ID: 23052164 [TBL] [Abstract][Full Text] [Related]
12. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications. Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275 [TBL] [Abstract][Full Text] [Related]
13. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer. Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378 [TBL] [Abstract][Full Text] [Related]
14. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience. Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296 [TBL] [Abstract][Full Text] [Related]
15. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
16. CT-based interstitial brachytherapy in advanced gynecologic malignancies: outcomes from a single institution experience. D'Souza D; Wiebe E; Patil N; Sugimoto A; Prefontaine M; Aulakh S; Whiston F; Stitt L; Surry K Brachytherapy; 2014; 13(3):225-32. PubMed ID: 24613570 [TBL] [Abstract][Full Text] [Related]
17. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362 [TBL] [Abstract][Full Text] [Related]
19. Lip cancer treatment with high dose rate brachytherapy. Guinot JL; Arribas L; Chust ML; Mengual JL; García Miragall E; Carrascosa M; Escolar PP; Crispín V; Guardino C Radiother Oncol; 2003 Oct; 69(1):113-5. PubMed ID: 14597364 [TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model. Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]